Biosynthetic alanine racemase (Alr PA ) from Pseudomonas aeruginosa PAO1 carrying a His 6 tag was expressed in Escherichia coli BL21 (DE3) cells and purified by Ni 2+ -chelating affinity and anion-exchange chromatography for X-ray crystallographic analysis. Crystals were grown by the hanging-drop vapour-diffusion method at 289 K in a solution consisting of 4%(v/v) Tacsimate pH 5.0, 14%(w/v) polyethylene glycol 3350 with a protein concentration of 8 mg ml À1 . The crystal diffracted to 2.76 Å resolution and belonged to the orthorhombic space group P2 1 2 1 2 1 , with unit-cell parameters a = 74.12, b = 76.97, c = 154.80 Å , = = = 90 .
Introduction
Pseudomonas aeruginosa is an important Gram-negative pathogen that is widely distributed in nature and in the respiratory tract and intestinal tract of humans. It is one of the most common causes of nosocomial infections, including infections in intensive care units (Jarvis & Martone, 1992) . Patients with cystic fibrosis are prone to a higher risk of life-threatening Pseudomonas infections (FitzSimmons, 1993) . The high antimicrobial resistance and fatality rate of P. aeruginosa have constituted a serious threat to the control of clinical infections in recent years. Therefore, it is vital to identify new antibiotics directed against this organism.
Alanine racemases (EC 5.1.1.1) have been isolated, purified and characterized from several different bacteria (Wood & Gunsalus, 1951; Rosso et al., 1969; Diven et al., 1964; Lambert & Neuhaus, 1972) . Alanine racemase belongs to the type III group of pyridoxal 5 0phosphate (PLP)-dependent enzymes and catalyzes the racemization of l-alanine to d-alanine, which is an indispensable building block in the synthesis of the peptidoglycan layer of cell walls, utilizing PLP as a cofactor. Alanine racemase is ubiquitous among prokaryotes but is absent in eukaryotes. Therefore, it is an attractive target for the development of new antimicrobial drugs (Lambert & Neuhaus, 1972; Silverman, 1988) .
In P. aeruginosa PAO1 there are two independent alanine racemase genes that encode biosynthetic alanine racemase (alr PA ) and catabolic alanine racemase (dadX PA ) (Strych et al., 2000) . The aminoacid sequence of Alr PA is 50% identical to the sequence of DadX PA (PDB entry 1rcq; LeMagueres et al., 2003; Fig. 1) . Based on the apparent molecular weight as analyzed by gel filtration, native PAGE and analytical ultracentrifugation, Alr PA and DadX PA are intermediate between monomeric and dimeric forms (Ju et al., 2011) . However, crystal structure analysis demonstrated that DadX PA is a dimer (LeMagueres et al., 2003) . Moreover, intermolecular complementation analysis between two defective mutants of Alr PA indicated that the enzyme functions exclusively as a homodimer (Strych & Benedik, 2002) .
The structure of biosynthetic alanine racemase (Alr PA ) from P. aeruginosa PAO1 has not previously been reported. In order to elucidate the biochemical properties of Alr PA and its mode of substrate recognition, a structural investigation was initiated. Here, we report our progress on the crystallization and preliminary X-ray diffraction data collection of the recombinant Alr PA protein carrying a His 6 tag. The three-dimensional structure of this protein is being determined.
Materials and methods

Cloning, expression and purification
The gene encoding Alr PA (GenBank accession No. NP_253617) was amplified from P. aeruginosa PAO1 genomic DNA by PCR using the primers 5 0 -CGGGATCCTCAGTGGCTGTAGCGTCGCG-3 0 and 5 0 -GGCTCGAGATGCGTCCCCTCGTTGCCAC-3 0 , where the bold sequences represent BamHI and XhoI restriction sites, respectively. The PCR product was digested with BamHI and XhoI and inserted into the expression vector pET-22b(+) (Novagen, USA). The recombinant plasmid was transformed into Escherichia coli BL21 (DE3) cells (Novagen, USA). The transformed cells were grown in 800 ml LB medium containing 100 mg ml À1 ampicillin at 310 K until the OD 600 reached 0.6-0.8. The culture was cooled and induced overnight at 289 K with 1 mM isopropyl -d-1-thiogalactopyranoside (IPTG; final concentration).
The cells were harvested by centrifugation at 8600g and 277 K for 15 min and resuspended in 25 ml lysis buffer [50 mM Tris-HCl pH 8.0, 5%(v/v) glycerol, 200 mM NaCl]. After the cells had been homogenized using a high-pressure homogenizer (JNBIO, People's Republic of China), the insoluble cell debris was removed by centrifugation at 48 400g for 30 min at 277 K. The supernatant containing crude protein was loaded onto an Ni 2+ -chelating affinity chromatography column (HiTrap Chelating HP, GE Healthcare, USA) and rinsed with 100 ml wash buffer [50 mM Tris-HCl pH 8.0, 5%(v/v) glycerol, 200 mM NaCl, 50 mM imidazole] to remove nonspecifically bound proteins. The bound Alr PA protein was eluted with 8 ml elution buffer [50 mM Tris-HCl pH 8.0, 5%(v/v) glycerol, 200 mM NaCl, 200 mM imidazole]. The eluate was dialyzed against 50 mM Tris-HCl buffer pH 8.0 with 5%(v/v) glycerol, and further loaded onto an anion-exchange chromatography column (1 ml Q HP HiTrap column, GE Healthcare, USA) and eluted using an NaCl gradient. The purified Alr PA protein was dialyzed against 50 mM Tris-HCl buffer pH 8.0 with 5%(v/v) glycerol and concentrated to 20 mg ml À1 at 277 K using an Amicon Ultra centrifugal filter device (30 kDa molecular-weight cutoff; Millipore). The purity of Alr PA was analyzed by 12% SDS-PAGE and the protein concentration was determined using a NanoDrop device (Thermo Scientific, USA) by recording the absorption at 280 nm.
Crystallization
Initial crystallization screening was performed in 96-well plates at 289 K using the hanging-drop vapour-diffusion method with commercial crystallization kits from Hampton Research (Crystal Screen, Crystal Screen 2, Index and PEG/Ion kits). The protein concentrations for crystallization screening were 5 and 10 mg ml À1 in 50 mM Tris-HCl buffer pH 8.0, 5%(v/v) glycerol with 10 mM PLP. For optimization, drops composed of 1 ml protein solution mixed with an equal volume of reservoir solution were equilibrated against 80 ml reservoir solution. Optimization of crystallization conditions was based on the initial screening by adjustment of the precipitant concentration, the protein concentration and the buffer pH.
X-ray data collection and processing
For X-ray diffraction experiments, the crystals were quick-soaked in reservoir solution containing 15%(v/v) glycol as a cryoprotectant for 15-20 s. The soaked crystals were mounted in nylon loops and flash-cooled in liquid nitrogen at 100 K for data collection (Teng, 1990; Parkin & Hope, 1998) . A X-ray diffraction data set was collected at 100 K using an in-house X-ray source (Rigaku MicroMax-007 HF desktop rotating-anode X-ray generator with a Cu target operated at 40 kV and 30 mA) and a Saturn 944+ detector with a 70 mm crystal-to-detector distance at a wavelength of 1.5418 Å . 360 diffraction frames were collected with 0.5 oscillation per image at 100 K. The crystal diffracted to 2.76 Å resolution. The diffraction data set was indexed, integrated and subsequently scaled using HKL-2000 (Otwinowski & Minor, 1997) . The data quality was assessed using SFCHECK (Vaguine et al., 1999) and the solvent content was calculated using MATTHEWS_COEF from CCP4 (Winn et al., 2011) . Table 1 gives a summary of data collection and processing.
Results
The gene encoding the Alr PA protein was amplified from P. aeruginosa PAO1 and cloned into the expression vector pET-22b(+). The recombinant Alr PA with a His 6 tag was expressed in E. coli strain BL21 (DE3) and purified by Ni 2+ -chelating affinity and anionexchange chromatography to electrophoretic homogeneity. The molecular weight of Alr PA was estimated to be about 39 kDa by SDS-PAGE analysis (Fig. 2) , coinciding with the calculated molecular weight of 38.3 kDa for recombinant Alr PA with a His 6 tag at the C-terminus. 
Figure 4
Typical X-ray diffraction pattern of an Alr PA crystal. The frame edge is at 2.76 Å resolution. Initial crystallization screening was performed in 96-well plates at 289 K using the hanging-drop vapour-diffusion method. (Fig. 3) were obtained using a solution consisting of 4%(v/v) Tacsimate pH 5.0, 14%(w/v) polyethylene glycol 3350 and a protein concentration of 8 mg ml À1 .
The crystals diffracted to beyond 2.5 Å resolution. Considering that the completeness in the highest resolution shell is below 70% at higher resolution, the highest resolution of the data was cut off at 2.76 Å . The crystal belonged to the orthorhombic space group P2 1 2 1 2 1 (Table 1) , with unit-cell parameters a = 74.12, b = 76.97, c = 154.80 Å , = = = 90 ( Fig. 4) . This data set has 98.1% overall completeness and 81.5% completeness in the highest resolution shell. The overall R merge is 10.6%. MOLREP (Vagin & Teplyakov, 2010) was employed to calculate the self-rotation peaks. A clear twofold axis in the self-rotation function indicated the presence of two molecules in the asymmetric unit. The solvent content and Matthews coefficient are 57.34% and 2.88 Å 3 Da À1 , respectively (Matthews, 1968) .
Alr PA shares 49% sequence identity with the alanine racemase from P. fluorescens (PDB entry 2odo; H. Tsuge, K. Ohnishi & K. Yokoigawa, unpublished work) and 50% sequence identity with DadX PA (PDB entry 1rcq; LeMagueres et al., 2003) (Fig. 1) . The BLAST scores of 1rcq and 2odo are 304 and 311, respectively. 2odo was finally used as a model for molecular replacement (MR). MOLREP (Vagin & Teplyakov, 2010) was employed to determine the initial phases using a monomer model of 2odo. We can see sharp rotation peaks and definite translation peaks in the Alr PA MR. A clear solution was obtained with an R free of 26.23% and an R work of 19.32% using data in the resolution range 50.00-2.76 Å . The threedimensional structure of Alr PA will provide insight into the biochemical properties and the oligomerization state of biosynthetic alanine racemase from P. aeruginosa PAO1.
